You are here >   Sponsorship > Current Sponsors
  |  Login

Current Sponsors


BayHelix appreciate the generous support of the following sponsors. The resources they provide help us to accomplish our missions and bring value to the life science industry, the community, and our individual members.


Hangzhou Economic and Technological Development Area

HEDA was founded in 1993 as a state-level industrial area. It is located in the east of Hangzhoucovering a total jurisdiction of 104.7 sqkm and a population of 400,000.Over the past 2 decades, HEDA has attracted investors over 50 countries and area, among them, 67 projects of 55 Fortune 500 companies have settled in HEDA. In 2013, the industrial gross value of HEDA reached 15.55 billion RMB, and the fiscal revenue of HEDA reached 10.5 billion RMB. As one of the 3 satellite cities of Hangzhou, HEDA is endeavoring to build a new city combining high-tech industries, R&D Institutions, university town and residence area.

HEDA has been ranked top 1 among industrial areas in Zhejiang Province in terms of comprehensive competitiveness, and it also has been ranked among top 10 of the industrial areas nationwide.


Wuhan BioLakespacer





Since 1993, BioCentury Publications, Inc. has been internationally recognized as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of life science ventures.


BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions, conferences, and eLearning programs — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.


The company publishes the weekly editions of its flagship publication, BioCentury®, and BioCentury Week in Review, plus daily editions of BioCentury Extra. BioCentury also publishes BioCentury Innovations a weekly translational science journal.


The company also markets BCIQ, the industry's premiere business intelligence and research database. It provides easy access to data on thousands of companies and products and $400+ billion in financings.



Finnegan is one of the largest law firms in the world focusing solely on intellectual property law.  Founded in 1965 by the late Marcus Finnegan and our senior partner Douglas B. Henderson, Finnegan has grown from a two-member partnership to a firm of over 375 lawyers practicing all aspects of IP law. 

The firm is widely recognized as one of the leading intellectual property law firms in the world.  Managing Intellectual Property has named Finnegan as the Full Service IP Firm of the Year for North America for four years in a row (2008-2011).  In its annual World IP surveys of 4,000 global practitioners, MIP has consistently ranked the firm in the first or second tiers of U.S. law firms for Patent Contentious and Prosecution  (2002-2011) and for Trademark Contentious and Prosecution (2005-2011).  In other surveys, Chambers Global ranked the firm as a first tier U.S. intellectual property law firm in its 2009 and 2010 editions.  The Legal 500 U.S, 2010 edition ranks the firm as first tier for patent litigation, patent prosecution, trademark noncontentious, trademark litigation, and licensing. Please visit us at:

IMS Health


IMS Health is the leading provider of information, services and technology for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, sophisticated analytics, on-shore and off-shore commercial services, and software platforms to help clients better understand the performance and value of medicines. With a presence in 100+ countries and more than 55 years of industry experience, IMS serves leading decision makers in healthcare, including pharmaceutical manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at

CST China


Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 350 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine. For more information, please visit:

To better serve customers in China, CST China subsidiary was established in October of 2008, we build up technical support team, set up local inventory which covers most antibodies in common usage. For more information, please visit:





ALEXANDRIA REAL ESTATE EQUITIES, INC. (NYSE:ARE), Landlord of Choice to the Life Science Industry®, is the largest owner and preeminent real estate investment trust ("REIT") focused principally on cluster development through the ownership, operation, management, selective redevelopment, development, and acquisition of properties containing office/laboratory space. Alexandria is the leading provider of high-quality environmentally sustainable real estate, technical infrastructure, and services to the broad and diverse life science industry. Client tenants include institutional (universities and independent not-for-profit institutions), pharmaceutical, biotechnology, medical device, product, service, and translational entities, as well as government agencies. Alexandria's operating platform is based on the principle of "clustering", with assets and operations located in key life science markets.

 Cooley LLP spacer